Glaxosmithkline Biologicals
SpainAll drugs from this manufacturer
-
It is a vaccine designed to help protect adults aged 18 years and older against respiratory syncytial virus (RSV), a virus that can cause lung infections and other respiratory complications.
Dosage form: powder and suspension for injectable suspension
Active substance Dosage vaccine (rsvpref) of stabilized f subunit in prefusion against respiratory syncytial virus 120 µg -
This vaccine is used to protect individuals from 9 years of age against diseases caused by human papillomavirus (HPV) types 16 and 18, including cervical cancer, anal cancer, and precancerous lesions of the vulva, vagina, and anus.
Dosage form: suspension for injection, in pre-filled syringe
Active substance Dosage human papillomavirus type 16 l1 protein 20 µg human papillomavirus type 18 l1 protein 20 µg -
It is a vaccine used to prevent hepatitis B, especially in adults and young people aged 15 and older who have kidney problems, such as patients undergoing hemodialysis or those who will undergo it in the future.
Dosage form: suspension for injection, in pre-filled syringe
Active substance Dosage hepatitis b surface antigen 20 µg -
This vaccine is used to protect children against six diseases: diphtheria, tetanus, pertussis, hepatitis B, polio, and Haemophilus influenzae type b (Hib) infection.
Dosage form: powder and solvent for injectable suspension
Active substance Dosage diphtheria toxoid 30 UI tetanus toxoid 40 UI h. influenzae type b polysaccharide tetanus toxoid conjugate 0,02 mg haemophilus influenzae type b 0,01 mg bordetella pertussis toxoid 0,025 mg bordetella pertussis filamentous hemagglutinin 0,025 mg bordetella pertussis 69 kd outer membrane protein 0,01 mg poliovirus type i 40 U.D. (UNIDADES ANTIGENICAS D) poliovirus type ii 8 U.D. (UNIDADES ANTIGENICAS D) poliovirus type iii 32 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 0,01 mg -
This vaccine is used to protect children against six diseases: diphtheria, tetanus, pertussis, hepatitis B, polio, and Haemophilus influenzae type b (Hib) infection.
Dosage form: powder and solvent for injectable suspension
Active substance Dosage diphtheria toxoid 30 UI tetanus toxoid 40 UI h. influenzae type b polysaccharide tetanus toxoid conjugate 20 µg haemophilus influenzae type b 10 µg bordetella pertussis toxoid 25 µg bordetella pertussis filamentous hemagglutinin 25 µg bordetella pertussis 69 kd outer membrane protein 10 µg poliovirus type i 40 U.D. (UNIDADES ANTIGENICAS D) poliovirus type ii 8 U.D. (UNIDADES ANTIGENICAS D) poliovirus type iii 32 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 10 µg -
This vaccine helps protect children, from 6 weeks of age, against gastroenteritis (diarrhea and vomiting) caused by rotavirus.
Dosage form: suspension, oral
Active substance Dosage human rotavirus 10 MILLONES GERMENES -
This vaccine helps protect children, from 6 weeks of age, against gastroenteritis (diarrhea and vomiting) caused by rotavirus infection.
Dosage form: suspension, oral
Active substance Dosage human rotavirus 10 MILLONES GERMENES -
This vaccine helps protect adults against herpes zoster (shingles) and postherpetic neuralgia (PHN), which is the long-term pain caused by nerve damage following shingles.
Dosage form: powder and suspension for injectable suspension
Active substance Dosage recombinant glycoprotein e (ge) antigen of varicella zoster virus (vzv) 50 µg -
This vaccine is used in adults and adolescents aged 16 years or older to prevent hepatitis A and hepatitis B.
Dosage form: suspension for injection, in pre-filled syringe
Active substance Dosage hepatitis a antigen 720 U ELISA hepatitis b surface antigen 20 µg -
It is used in children and adolescents between 1 and 15 years of age to prevent hepatitis A and hepatitis B, helping the body produce its own antibodies against these diseases.
Dosage form: suspension for injection, in pre-filled syringe
Active substance Dosage hepatitis a antigen 360 U ELISA hepatitis b surface antigen 10 µg